N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexatriaconta-4,8-dien-2-yl]nonadecanamide

C67H127NO13 — CID 165181217

IUPACN-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexatriaconta-4,8-dien-2-yl]nonadecanamide
SMILESCCCCCCCCCCCCCCCCCCCCCCCCCCC/C=C/CC/C=C/C(O)C(COC1OC(CO)C(OC2OC(CO)C(O)C(O)C2O)C(O)C1O)NC(=O)CCCCCCCCCCCCCCCCCC
InChIInChI=1S/C67H127NO13/c1-3-5-7-9-11-13-15-17-19-21-22-23-24-25-26-27-28-29-30-31-32-33-34-35-36-38-40-42-44-46-48-50-56(71)55(68-59(72)51-49-47-45-43-41-39-37-20-18-16-14-12-10-8-6-4-2)54-78-66-64(77)62(75)65(58(53-70)80-66)81-67-63(76)61(74)60(73)57(52-69)79-67/h40,42,48,50,55-58,60-67,69-71,73-77H,3-39,41,43-47,49,51-54H2,1-2H3,(H,68,72)/b42-40+,50-48+
InChIKeyABZLFAIPGKLZHA-JGIQRELWSA-N
MW1154.75 g/mol
LogP13.18
Rot. Bonds56

About N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexatriaconta-4,8-dien-2-yl]nonadecanamide

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexatriaconta-4,8-dien-2-yl]nonadecanamide (PubChem CID 165181217) has the molecular formula C67H127NO13 and a molecular weight of 1154.75 g/mol. Its IUPAC name is N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexatriaconta-4,8-dien-2-yl]nonadecanamide.

Molecular Properties

Compound NameN-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexatriaconta-4,8-dien-2-yl]nonadecanamide
PubChem CID165181217
Molecular FormulaC67H127NO13
Molecular Weight1154.75 g/mol
Exact Mass1153.93
IUPAC NameN-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexatriaconta-4,8-dien-2-yl]nonadecanamide
SMILESCCCCCCCCCCCCCCCCCCCCCCCCCCC/C=C/CC/C=C/C(O)C(COC1OC(CO)C(OC2OC(CO)C(O)C(O)C2O)C(O)C1O)NC(=O)CCCCCCCCCCCCCCCCCC
InChIInChI=1S/C67H127NO13/c1-3-5-7-9-11-13-15-17-19-21-22-23-24-25-26-27-28-29-30-31-32-33-34-35-36-38-40-42-44-46-48-50-56(71)55(68-59(72)51-49-47-45-43-41-39-37-20-18-16-14-12-10-8-6-4-2)54-78-66-64(77)62(75)65(58(53-70)80-66)81-67-63(76)61(74)60(73)57(52-69)79-67/h40,42,48,50,55-58,60-67,69-71,73-77H,3-39,41,43-47,49,51-54H2,1-2H3,(H,68,72)/b42-40+,50-48+
InChIKeyABZLFAIPGKLZHA-JGIQRELWSA-N
XLogP13.18
TPSA227.86 Ų
H-Bond Donors9
H-Bond Acceptors13
Rotatable Bonds56
Heavy Atoms81
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001154.75
LogP ≤ 513.18
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexatriaconta-4,8-dien-2-yl]nonadecanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexatriaconta-4,8-dien-2-yl]nonadecanamide?
The IUPAC name of N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexatriaconta-4,8-dien-2-yl]nonadecanamide (CID 165181217) is N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexatriaconta-4,8-dien-2-yl]nonadecanamide.
What is the SMILES notation for N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexatriaconta-4,8-dien-2-yl]nonadecanamide?
The canonical SMILES for N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexatriaconta-4,8-dien-2-yl]nonadecanamide is CCCCCCCCCCCCCCCCCCCCCCCCCCC/C=C/CC/C=C/C(O)C(COC1OC(CO)C(OC2OC(CO)C(O)C(O)C2O)C(O)C1O)NC(=O)CCCCCCCCCCCCCCCCCC.
What is the InChIKey of N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexatriaconta-4,8-dien-2-yl]nonadecanamide?
The InChIKey is ABZLFAIPGKLZHA-JGIQRELWSA-N. The full InChI is InChI=1S/C67H127NO13/c1-3-5-7-9-11-13-15-17-19-21-22-23-24-25-26-27-28-29-30-31-32-33-34-35-36-38-40-42-44-46-48-50-56(71)55(68-59(72)51-49-47-45-43-41-39-37-20-18-16-14-12-10-8-6-4-2)54-78-66-64(77)62(75)65(58(53-70)80-66)81-67-63(76)61(74)60(73)57(52-69)79-67/h40,42,48,50,55-58,60-67,69-71,73-77H,3-39,41,43-47,49,51-54H2,1-2H3,(H,68,72)/b42-40+,50-48+.
What are the key properties of N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexatriaconta-4,8-dien-2-yl]nonadecanamide?
N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexatriaconta-4,8-dien-2-yl]nonadecanamide has a molecular weight of 1154.75 g/mol, XLogP of 13.18, 56 rotatable bonds, 9 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexatriaconta-4,8-dien-2-yl]nonadecanamide is sourced from PubChem (CID 165181217), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).